# Biochemical Effects of Remote Ischemic Pre-Conditioning on Contrast-induced Acute Kidney Injury

Study · id `cardio:ct-nct03236441` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03236441](<https://clinicaltrials.gov/study/NCT03236441>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03236441

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

## Technical summary

Registry record NCT03236441. Randomized; quadruple masking; primary purpose treatment. Start 2018-03-06 (actual); primary completion 2023-02-28 (actual). Results posted on 2025-01-09.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT03236441, source copy `cardio:ctgov-nct03236441-2025-01-09`, retrieved 2026-10-26)
- Started: 2018-03-06 (actual) (ClinicalTrials.gov record NCT03236441, source copy `cardio:ctgov-nct03236441-2025-01-09`, retrieved 2026-10-26)
- Primary completion: 2023-02-28 (actual) (ClinicalTrials.gov record NCT03236441, source copy `cardio:ctgov-nct03236441-2025-01-09`, retrieved 2026-10-26)
- Completion: 2024-02-28 (actual) (ClinicalTrials.gov record NCT03236441, source copy `cardio:ctgov-nct03236441-2025-01-09`, retrieved 2026-10-26)
- Results first posted: 2025-01-09 (ClinicalTrials.gov record NCT03236441, source copy `cardio:ctgov-nct03236441-2025-01-09`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT03236441, source copy `cardio:ctgov-nct03236441-2025-01-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03236441-2025-01-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Biochemical Effects of Remote Ischemic Pre-Conditioning on Contrast-induced Acute Kidney Injury
- Acronym: BRICK
- Condition: Contrast-induced Acute Kidney Injury
- Intervention (Device): RIPC
- Intervention (Device): Sham-RIPC
- Lead sponsor: Oladipupo Olafiranye, MD, MS
- Lead sponsor class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)

## Provenance

Content hash: 7547973500d46288798a9a1fda25529ad9472a1f94f93fbb38b0970605bcccc8
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
